Advertisement

Advertisement

GB:IMM Stock Latest News

ImmuPharma Secures Shareholder Backing and Funding to Drive P140 and Kapiglucagon Programs

Company AnnouncementsImmuPharma Secures Shareholder Backing and Funding to Drive P140 and Kapiglucagon Programs

ImmuPharma Wins Shareholder Backing for Major Share Allotment

PremiumCompany Announcements

ImmuPharma Wins Shareholder Backing for Major Share Allotment

6d ago

ImmuPharma Advances P140 Patent and Data as It Targets 2026 Licensing Deal

PremiumCompany Announcements

ImmuPharma Advances P140 Patent and Data as It Targets 2026 Licensing Deal

17d ago

ImmuPharma Raises £6.47m as Retail Offer Completes Ahead of AIM Share Admission

PremiumCompany Announcements

ImmuPharma Raises £6.47m as Retail Offer Completes Ahead of AIM Share Admission

21d ago

ImmuPharma Calls General Meeting to Approve Fundraising Plans

PremiumCompany Announcements

ImmuPharma Calls General Meeting to Approve Fundraising Plans

25d ago

ImmuPharma Sets Investor Presentation on Pipeline and £7.5m Fundraise

PremiumCompany AnnouncementsImmuPharma Sets Investor Presentation on Pipeline and £7.5m Fundraise

26d ago

ImmuPharma Launches £1.5m WRAP Retail Share Offer Alongside £7.5m Subscription

Company Announcements

ImmuPharma Launches £1.5m WRAP Retail Share Offer Alongside £7.5m Subscription

27d ago

ImmuPharma raises up to £7.5m to fast‑track Kapiglucagon as P140 licensing talks advance

Company Announcements

ImmuPharma raises up to £7.5m to fast‑track Kapiglucagon as P140 licensing talks advance

27d ago

ImmuPharma Targets Investor Visibility at JP Morgan Conference and Biotech Showcase

PremiumCompany Announcements

ImmuPharma Targets Investor Visibility at JP Morgan Conference and Biotech Showcase

3M ago

ImmuPharma Extends P140 Partnership Timeline Amid Strong Financial Position

PremiumCompany Announcements

ImmuPharma Extends P140 Partnership Timeline Amid Strong Financial Position

5M ago

ImmuPharma to Participate in Bio-Europe 2025

PremiumCompany Announcements

ImmuPharma to Participate in Bio-Europe 2025

6M ago

ImmuPharma Unveils New Website and Advances P140 Autoimmune Platform

PremiumCompany Announcements

ImmuPharma Unveils New Website and Advances P140 Autoimmune Platform

6M ago

ImmuPharma Appoints Ketan Patel as Independent Non-Executive Director

PremiumCompany AnnouncementsImmuPharma Appoints Ketan Patel as Independent Non-Executive Director

6M ago

ImmuPharma Announces Warrant Exercise and Share Admission

Company Announcements

ImmuPharma Announces Warrant Exercise and Share Admission

7M ago

ImmuPharma Announces Warrant Exercise and Share Capital Update

Company Announcements

ImmuPharma Announces Warrant Exercise and Share Capital Update

7M ago

ImmuPharma Strengthens Leadership with Key Appointments Amid New Patent Filing

PremiumCompany Announcements

ImmuPharma Strengthens Leadership with Key Appointments Amid New Patent Filing

7M ago

ImmuPharma Files Patent for Groundbreaking Autoimmune Disease Treatment

PremiumCompany Announcements

ImmuPharma Files Patent for Groundbreaking Autoimmune Disease Treatment

7M ago

ImmuPharma Reports Financial Loss Amidst P140 Platform Advancements

PremiumCompany Announcements

ImmuPharma Reports Financial Loss Amidst P140 Platform Advancements

8M ago

ImmuPharma Announces 2025 AGM Results with Majority Resolutions Passed

PremiumCompany Announcements

ImmuPharma Announces 2025 AGM Results with Majority Resolutions Passed

10M ago

ImmuPharma Announces Change in Major Shareholder Holdings

PremiumCompany AnnouncementsImmuPharma Announces Change in Major Shareholder Holdings

11M ago

ImmuPharma Announces AGM and Releases Annual Report

Company Announcements

ImmuPharma Announces AGM and Releases Annual Report

11M ago

ImmuPharma Advances P140 Platform with Key Discoveries and Strategic Partnerships

Company Announcements

ImmuPharma Advances P140 Platform with Key Discoveries and Strategic Partnerships

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >